Biotage AB (BIOT) - Financial and Strategic SWOT Analysis Review

Date: October 28, 2014
Pages: 50
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: B648B1863ACEN
Leaflet:

Download PDF Leaflet

Biotage AB (BIOT) - Financial and Strategic SWOT Analysis Review
Biotage AB (BIOT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - detailed description of the company’s operations and business divisions.
  • Corporate strategy - nalyst’s summarization of the company’s business strategy.
  • SWOT Analysis - detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - list of major products, services and brands of the company.
  • Key competitors - list of key competitors to the company.
  • Key employees - list of the key executives of the company.
  • Executive biographies - brief summary of the executives’ employment history.
  • Key operational heads - list of personnel heading key departments/functions.
  • Important locations and subsidiaries - list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Biotage AB (Biotage) is a biotechnology company. It provides comprehensive solutions in the field of medicinal and analytical chemistry, peptide synthesis, separation, and purification. The company is a global service provider of instruments, reagents and service to pharmaceutical and biotechnological companies and academic institutions. Biotage offers products under three categories, namely, Organic Chemistry, Analytical Chemistry and Industrial Resins. Its major products include microwave instruments such as Biotage Initrieator +, Biotage Initiator Classic, and Biotage Advancer; industrial resins such as Resna, and molecularly imprinted polymers (MIPs);sample preparation instruments such as Biotage Extrahera, Biotage Pressure, Biotage VacMaster 10 and 20, and RapidTrace among others; flash purification cartridges and systems; and reaction screening instruments. The company has wholly owned subsidiaries in Sweden, the UK, Germany, France, Switzerland, Italy, the US and Japan and offers its products across the world. Biotage is headquartered in Uppsala, Sweden.

Biotage AB Key Recent Developments

Oct 01, 2014: New Automated Sample Preparation System
Jul 01, 2014: New Application: Effective Extraction of Vitamin D Metabolites Utilizing ISOLUTE SLE
Jun 30, 2014: Biotage Launches ACI - ccelerated Chromatographic Isolation
Jun 17, 2014: New 1 mL ISOLUTE SLE+ 48-well Plates from Biotage - Extract Larger Sample Volumes, Faster
Feb 13, 2014: Biotage Reports Year-End Report for 2013

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Biotage AB - Key Facts
Biotage AB - Key Employees
Biotage AB - Key Employee Biographies
Biotage AB - Major Products and Services
Biotage AB - History
Biotage AB - Company Statement
Biotage AB - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Biotage AB - Key Manufacturing Facilities

SECTION 2 – COMPANY ANALYSIS

Biotage AB - Business Description
Biotage AB - Corporate Strategy
Biotage AB - SWOT Analysis
SWOT Analysis - Overview
Biotage AB - Strengths
Strength - Focused Research and Development Activities
Strength - Strong Geographical Presence
Strength - Strong Customer Base
Biotage AB - Weaknesses
Weakness - Weak Liquidity Position
Weakness - Weakened Operational Performance
Weakness - Product Discontinuation
Biotage AB - Opportunities
Opportunity - Growing Aged Population
Opportunity - New Manufacturing Plant
Opportunity - New Product Launches
Biotage AB - Threats
Threat - Competition and Technological Change
Threat - Stringent Governmental Regulations
Threat - Changing Diagnostic Market Conditions
Biotage AB - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Biotage AB, Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Biotage AB, Pharmaceuticals & Healthcare, Deals By Type, 2008 to YTD 2014
Biotage AB, Medical Equipment, Deals By Year, 2008 to YTD 2014
Biotage AB, Medical Equipment, Deals By Type, 2008 to YTD 2014
Biotage AB, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Jun 30, 2014: Biotage Launches ACI - Accelerated Chromatographic Isolation
Feb 13, 2014: Biotage Reports Year-End Report for 2013
Nov 08, 2013: New Manufacturing Plant Opens in Ystrad Mynach
Oct 25, 2013: Biotage: Interim Report for the Period January - September 2013
Aug 15, 2013: Biotage Announces Interim report for the period January - June 2013
Jan 16, 2013: Biotage Receives Positive Ruling From US Patent and Trademark Office’s Patent Trial And Appeal Board In Re-examination Proceedings

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Biotage AB, Key Facts
Biotage AB, Key Employees
Biotage AB, Key Employee Biographies
Biotage AB, Major Products and Services
Biotage AB, History
Biotage AB, Other Locations
Biotage AB, Subsidiaries
Biotage AB, Key Manufacturing Facilities
Biotage AB, Key Competitors
Biotage AB, Ratios based on current share price
Biotage AB, Annual Ratios
Biotage AB, Interim Ratios
Biotage AB, Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Biotage AB, Pharmaceuticals & Healthcare, Deals By Type, 2008 to YTD 2014
Biotage AB, Medical Equipment, Deals By Year, 2008 to YTD 2014
Biotage AB, Medical Equipment, Deals By Type, 2008 to YTD 2014
Biotage AB, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Biotage AB, Performance Chart (2009 - 2013)
Biotage AB, Ratio Charts
Biotage AB, Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Biotage AB, Pharmaceuticals & Healthcare, Deals by Type, 2008 to YTD 2014
Biotage AB, Medical Equipment, Deals By Year, 2008 to YTD 2014
Biotage AB, Medical Equipment, Deals by Type, 2008 to YTD 2014

Ask Your Question

Biotage AB (BIOT) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: